EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
批准号:
6302440
负责人:
PAUL JOHN BERTICS
金额:
$22.9万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30
关键词:
antiport apoptosis asthma cell adhesion chemotaxis cytokine receptors enzyme activity eosinophil human tissue immunoregulation inflammation integrins interleukin 5 leukotrienes mitogen activated protein kinase phosphorylation receptor binding receptor expression tissue /cell culture transcription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Allergic inflammation and asthma are characterized by eosinophilia and
the increased production of interleukin 5 (Il-5) in blood and affected
tissues. Eosinophils can promote both bronchial smooth muscle
contraction and increased permeability of bronchial mucosa. Eosinophil-
derived mediators [e.g., granule proteins, reactive oxygen species and
leukotriene C4 (LTC4)], can evoke hyper-responsiveness, epithelial
damage, inflammation and bronchoconstriction. IL-5 is known to regulate
eosinophil function, which can contribute to the pathogenesis of asthma.
For example, IL-5 stimulation of blood eosinophils can produce several
functional changes that mirror the phenotypic characteristics of the
airway eosinophil, and these IL-5-induced changes include the priming
LTC4 release, the increased membrane expression of CD11b/CD18, the
enhance adherence to endothelial cells, and prolonged survival. Because
little is known about IL-5 signal transduction in eosinophils, the
present project is designed to explore the mechanisms by which Il-5
mediates alterations in eosinophil function, thereby increasing its
inflammatory potential. This proposal will test a model of IL-5
intracellular signaling processes that is based on studies by us and
others on the IL-5 family of cytokines. Our overall goal is to assess
the importance of various aspects of this model to the intracellular
events in human eosinophils stimulated with IL-5, and to relate these
signaling processes to eosinophil function. The studies will focus on
functional changes, namely chemotaxis, adherence to endothelium, LTC4
generation and suppression of apoptotic cell death, that are of
particular relevance to the inflammatory capacity and accumulation of
eosinophils in the pathogenesis of asthma.
The proposed research centers around our observation that IL-5
stimulates the tyrosine phosphorylation of several cellular proteins,
including the phosphorylation and activation of a 45-kDa mitogen-
activated protein kinase (MAP kinase). The central hypothesis is
developed that multiple pathways are involved in the IL-5 mediated
tyrosine phosphorylation and activation of MAP kinases in eosinophils.
To test this hypothesis, we will analyze the events that link IL-5
receptor activation to MAP kinase stimulation, such as pathways
encompassing tyrosine kinases, Ras, protein kinase C, and/or pertussis
toxin-sensitive G-proteins. Secondly, we will also examine selected
processes that may result from IL-5-stimulated MAP kinase activity,
including the regulation of phospholipase A2, ribosomal S6 kinase II
(Rsk) and the hematopoietic transcription factor GATA-2, since these
proteins are established MAP kinase substrates. These investigations
lead to the related hypothesis that MAP kinase activation is a key
intracellular mechanism, that along with other signaling events, is
associated with IL-5 mediated changes in eosinophil function, including
the priming of LTC4 generation, increased adherence to endothelial
cells, chemotaxis and suppression of apoptotic cell death. In sum, it
is anticipated that these studies will lead to a greater understanding
of the molecular processes associated with eosinophilic inflammation
that is a major characteristic of the pathophysiology of asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signal Transduction Pathways in Eosinophil Priming
-
批准号:7843280
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2009
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Signal Transduction Pathways in Eosinophil Priming
-
批准号:7391415
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7603015
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7240191
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Molecular Analysis Using Liquid Crystal Technology
-
批准号:7418290
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2007
-
负责人:PAUL JOHN BERTICS
-
依托单位:
Rhinovirus Stimulation of Macrophage Signaling /Mediator
-
批准号:7151330
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2006
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL-5 receptor activation and eosinophil signal transduction
-
批准号:6565042
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL-5 receptor activation and eosinophil signal transduction
-
批准号:6630927
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2002
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6410556
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2000
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6340663
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2000
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6201182
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1999
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6110689
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1998
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6099725
-
项目类别:
-
资助金额:$15.45万
-
财政年份:1998
-
负责人:PAUL JOHN BERTICS
-
依托单位:
IL 5 REGULATION OF EOSINOPHIL SIGNAL TRANSDUCTION AND FUNCTION
-
批准号:6235187
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1997
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6273183
-
项目类别:
-
资助金额:$22.41万
-
财政年份:1997
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EFFECT OF INTERLEUKIN 5 RECEPTOR ACTIVATION ON EOSINOPHIL SIGNAL TRANSDUCTION
-
批准号:6242683
-
项目类别:
-
资助金额:$21.78万
-
财政年份:1996
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:2092768
-
项目类别:
-
资助金额:$12.13万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:3191707
-
项目类别:
-
资助金额:$7.93万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:2192614
-
项目类别:
-
资助金额:$14.66万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
EGF RECEPTOR FUNCTION AND CONTROL BY PHOSPHORYLATION
-
批准号:3191704
-
项目类别:
-
资助金额:$7.78万
-
财政年份:1988
-
负责人:PAUL JOHN BERTICS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: